Sutro Biopharma, Inc. (STRO)

Sutro Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	242	261	464	689	838	254
Market Cap Growth	26.93%	-43.69%	-32.55%	-17.85%	229.97%	23.24%
Enterprise Value	-44	-81	180	547	494	146
PE Ratio	-	-2.45	-3.90	-6.52	-26.09	-4.56
PS Ratio	1.57	1.70	6.85	11.13	19.62	5.94
PB Ratio	2.47	1.75	2.14	2.73	2.52	2.60
P/FCF Ratio	-2.96	-2.26	-107.77	-7.10	-11.18	-3.71
P/OCF Ratio	-3.06	-2.34	130.85	-8.43	-12.36	-3.91
EV/Sales Ratio	0.43	-0.53	2.65	8.84	11.55	3.42
EV/EBITDA Ratio	-0.88	1.21	-1.71	-5.91	-20.78	-3.13
EV/EBIT Ratio	-0.77	1.05	-1.58	-5.34	-17.60	-2.84
EV/FCF Ratio	-0.56	0.70	-41.68	-5.64	-6.59	-2.13
Debt / Equity Ratio	0.29	0.22	0.23	0.23	0.07	0.10
Debt / EBITDA Ratio	-0.37	-0.50	-0.48	-0.62	-1.03	-0.21
Debt / FCF Ratio	-0.24	-0.29	-11.70	-0.59	-0.33	-0.14
Quick Ratio	4.34	4.40	5.14	5.06	12.66	3.77
Current Ratio	4.46	4.50	5.31	5.24	12.78	3.90
Asset Turnover	0.35	0.36	0.18	0.17	0.15	0.24
Interest Coverage	-8.34	-6.92	-33.88	-32.64	-7.06	-11.81
Return on Equity (ROE)	-89.30%	-70.90%	-54.40%	-36.70%	-14.90%	-48.70%
Return on Assets (ROA)	-26.00%	-24.80%	-31.90%	-29.50%	-11.30%	-31.00%
Return on Capital (ROIC)	-82.19%	-48.71%	-48.21%	-31.79%	-19.93%	-51.52%
Earnings Yield	-47.48%	-40.84%	-25.67%	-15.33%	-3.83%	-21.95%
FCF Yield	-49.23%	-44.33%	-0.93%	-14.09%	-8.94%	-26.97%
Buyback Yield / Dilution	-4.66%	-18.57%	-10.02%	-41.58%	-41.88%	-298.66%
Total Shareholder Return	-4.66%	-18.57%	-10.02%	-41.58%	-41.88%	-298.66%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).